With the introduction of monoclonal antibodies in immunohistochemistry
and immunocytology the detection of single disseminated tumor cells b
ecame achievable. In breast cancer as well as in gastric, colorectal,
pancreatic, lung, and other malignant tumors disseminated tumor cells
are present in bone marrow aspirations with a high prevalence. The fre
quency of positive aspirations as well as the average cell number corr
elate with the tumor stage. Regarding the prognostic significance of t
he so-called micrometastases several groups could demonstrate, that th
e presence of these cells in bone marrow, lymph nodes or peritoneal wa
shings is an independent risk factor for tumor relapse and survival. F
uture investigations should focus on the quantitative aspect of microm
etastases, the phenotype, and the tumorigenic potential of the individ
ual micrometastatic cells.